2BB score and signals
Contineum Therapeutics, Inc.’s current 2BB score is 25 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 8 | Very Low |
| Momentum | 31 | Weakening |
| Financial strength | 31 | Weak |
| Quality | 80 | Very Strong |
| Risk | 38 | Low |
Company facts
| Founded | 2009 |
| Employees | 51 |
| 52-week range | $6.56 – $16.91 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-10-28 | — | -0.4634 | — | $0.00 |
| 2026-08-18 | — | -0.4607 | — | $0.00 |
| 2026-05-05 | -0.39 | -0.5421 | $0.00 | $0.00 |
| 2026-03-05 | -0.49 | -0.4138 | $0.00 | $6.12M |
Related companies
2BBBullish & Bearish